• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Management of urinary incontinence.

作者信息

Demaagd George A, Davenport Timothy C

出版信息

P T. 2012 Jun;37(6):345-361H.

PMID:22876096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411204/
Abstract
摘要

相似文献

1
Management of urinary incontinence.尿失禁的管理
P T. 2012 Jun;37(6):345-361H.
2
No. 186-Conservative Management of Urinary Incontinence.第186号——尿失禁的保守治疗
J Obstet Gynaecol Can. 2018 Feb;40(2):e119-e125. doi: 10.1016/j.jogc.2017.11.027.
3
Continence management in acute stroke: a survey of current practices in Australia.急性脑卒中患者的控尿管理：澳大利亚现状调查。
J Adv Nurs. 2011 Jan;67(1):94-104. doi: 10.1111/j.1365-2648.2010.05480.x. Epub 2010 Oct 24.
4
Impact of bowel management in alleviating symptoms of urinary incontinence in patients with spina bifida associated with overactive bladder and detrusor sphincter dyssynergia.肠道管理对缓解伴有逼尿肌过度活动和尿道括约肌协同失调的脊髓脊膜膨出相关尿失禁患者症状的影响。
BJU Int. 2019 Jan;123(1):118-123. doi: 10.1111/bju.14414. Epub 2018 Jul 25.
5
A Mobile App for Self-management of Urgency and Mixed Urinary Incontinence in Women: Randomized Controlled Trial.一款用于女性急迫性和混合性尿失禁自我管理的移动应用：随机对照试验。
J Med Internet Res. 2021 Apr 5;23(4):e19439. doi: 10.2196/19439.
6
Exploring literature on knowledge, attitudes, beliefs and practices towards urinary incontinence management: a scoping review.探索关于知识、态度、信念和实践的文献，以管理尿失禁：范围综述。
Int Urogynecol J. 2021 Mar;32(3):485-499. doi: 10.1007/s00192-020-04628-3. Epub 2021 Jan 6.
7
Incontinence pad usage in medical welfare facilities in Korea.韩国医疗福利设施中失禁垫的使用情况。
Int Neurourol J. 2013 Dec;17(4):186-90. doi: 10.5213/inj.2013.17.4.186. Epub 2013 Dec 31.
8
A critical overview of the evidence base for the contemporary surgical management of stress incontinence.当代压力性尿失禁外科治疗证据基础的批判性综述
Curr Opin Urol. 2008 Jul;18(4):370-6. doi: 10.1097/MOU.0b013e3282fdf8d5.
9
Management of mixed urinary incontinence: IUGA committee opinion.混合性尿失禁的管理：IUGA 委员会意见。
Int Urogynecol J. 2024 Feb;35(2):291-301. doi: 10.1007/s00192-023-05694-z. Epub 2024 Jan 22.
10
Conservative management for postprostatectomy urinary incontinence.前列腺切除术后尿失禁的保守治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD001843. doi: 10.1002/14651858.CD001843.pub5.

引用本文的文献

1
Modern Conservative Management Strategies for Female Stress Urinary Incontinence: A Systematic Review.女性压力性尿失禁的现代保守治疗策略：一项系统评价
J Clin Med. 2025 May 8;14(10):3268. doi: 10.3390/jcm14103268.
2
Urinary Incontinence (UI) in Saudi Female Population: Prevalence, Risk Factors, and Impact on Quality of Life.沙特女性人群中的尿失禁：患病率、危险因素及对生活质量的影响。
Healthcare (Basel). 2024 Nov 23;12(23):2340. doi: 10.3390/healthcare12232340.
3
Incontinence Is an Independent Risk Factor for Total Hip and Knee Arthroplasty.尿失禁是全髋关节和膝关节置换术的独立危险因素。
Arthroplast Today. 2024 Mar 14;27:101355. doi: 10.1016/j.artd.2024.101355. eCollection 2024 Jun.
4
Experiences of children's self-wetting (including urinary incontinence) in Cox's Bazar's Rohingya refugee camps, Bangladesh.孟加拉国科克斯巴扎尔罗兴亚难民营儿童尿床（包括尿失禁）的经历。
PLOS Glob Public Health. 2024 Mar 7;4(3):e0002362. doi: 10.1371/journal.pgph.0002362. eCollection 2024.
5
Artificial Urinary Sphincter With Bilateral Atrophic Kidneys and Accessory Renal Arteries in a Male Cadaveric Subject: A Case Report and Clinicopathological Reconciliation of Urinary Abnormalities and Embryogenetic Correlation of Vascular Aberrations.男性尸体标本中伴有双侧萎缩性肾脏和副肾动脉的人工尿道括约肌：病例报告及泌尿系统异常的临床病理分析与血管畸形的胚胎发生学关联
Cureus. 2023 Apr 21;15(4):e37948. doi: 10.7759/cureus.37948. eCollection 2023 Apr.
6
State of the Art of Non-Invasive Technologies for Bladder Monitoring: A Scoping Review.非侵入性膀胱监测技术的最新进展：范围综述。
Sensors (Basel). 2023 Mar 2;23(5):2758. doi: 10.3390/s23052758.
7
Neurorehabilitation in Multiple Sclerosis-A Review of Present Approaches and Future Considerations.多发性硬化症的神经康复——当前方法与未来考量综述
J Clin Med. 2022 Nov 27;11(23):7003. doi: 10.3390/jcm11237003.
8
The efficacy of nebivolol on spontaneously hypertensive rats with overactive bladder - an experimental study.奈必洛尔对伴有膀胱过度活动症的自发性高血压大鼠的疗效——一项实验研究。
Arch Med Sci. 2019 Sep 26;18(5):1342-1350. doi: 10.5114/aoms.2019.88279. eCollection 2022.
9
Management of Sleep Disturbances in Parkinson's Disease.帕金森病睡眠障碍的管理。
J Parkinsons Dis. 2022;12(7):2029-2058. doi: 10.3233/JPD-212749.
10
The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study.在英国，患有下尿路症状（LUTS）的男性和女性中使用单一药物和联合药物治疗：一项回顾性观察研究。
BMC Urol. 2021 Sep 2;21(1):119. doi: 10.1186/s12894-021-00881-w.

本文引用的文献

1
Prospective Study Comparing the Suprapubic Arc (Sparc) Procedure and the Transobturator (Monarc) Procedure for Treating Female Stress Urinary Incontinence.比较耻骨上弧形（Sparc）手术和经闭孔（Monarc）手术治疗女性压力性尿失禁的前瞻性研究。
Low Urin Tract Symptoms. 2010 Apr;2(1):37-42. doi: 10.1111/j.1757-5672.2010.00061.x. Epub 2010 Feb 11.
2
Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.他达拉非 2.5 或 5 毫克每日一次治疗 12 周治疗勃起功能障碍合并良性前列腺增生症状和体征的男性患者：一项随机、安慰剂对照、双盲研究的结果。
J Sex Med. 2012 Jan;9(1):271-81. doi: 10.1111/j.1743-6109.2011.02504.x. Epub 2011 Oct 7.
3
Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.增加锯棕榈提取物剂量对下尿路症状的影响：一项随机试验。
JAMA. 2011 Sep 28;306(12):1344-51. doi: 10.1001/jama.2011.1364.
4
Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.每日一次他达拉非治疗下尿路症状提示良性前列腺增生症男性患者的疗效和安全性：一项国际随机、双盲、安慰剂对照试验的结果。
Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12.
5
Combined tadalafil and α-blocker therapy for benign prostatic hyperplasia in patients with erectile dysfunction: a multicenter, prospective study.他达拉非与α受体阻滞剂联合治疗勃起功能障碍患者的良性前列腺增生：一项多中心前瞻性研究。
J Androl. 2012 May-Jun;33(3):397-403. doi: 10.2164/jandrol.111.013185. Epub 2011 Aug 25.
6
Update on the treatment of overactive bladder.治疗膀胱过度活动症的最新进展。
Curr Opin Urol. 2011 Jul;21(4):286-90. doi: 10.1097/MOU.0b013e3283468da3.
7
Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder.在患有膀胱过度活动症的受试者中，使用非索罗定 4 毫克治疗的第一周对膀胱日记和患者报告的结果的影响。
Curr Med Res Opin. 2011 May;27(5):1059-65. doi: 10.1185/03007995.2011.565044. Epub 2011 Mar 23.
8
Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach.抗毒蕈碱药物治疗膀胱过度活动症的不良事件评估：网络荟萃分析方法。
PLoS One. 2011 Feb 23;6(2):e16718. doi: 10.1371/journal.pone.0016718.
9
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms.在有膀胱过度活动症症状的男性和女性中，非索罗定治疗的长期安全性、耐受性和疗效。
Curr Med Res Opin. 2011 May;27(5):921-30. doi: 10.1185/03007995.2011.559581. Epub 2011 Mar 1.
10
Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.比较细胞色素 P450 2D6 广泛代谢型和弱代谢型个体中非索罗定与托特罗定延长释放制剂的药代动力学变异性。
Br J Clin Pharmacol. 2011 Aug;72(2):226-34. doi: 10.1111/j.1365-2125.2011.03948.x.